Astrazeneca plc
NASDAQ: AZN
$67.01
+$0.43 (+0.6%)
Closing Price on January 10, 2025
AZN Articles
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. We have an unusual cast of characters in this week’s...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The pharmaceutical industry has found a growing source...
Published:
The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once again why much of the criticism is justified. The FDA today said...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. These are Thursday’s top ten analyst research summary...
Published:
Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so the potential treatments are often directly tied as well. We did a recent dig down for...
Published:
Last Updated:
You can just see the TV advertisements now… Wal-Mart and Uncle Sam are “rolling back” swine flu. The retailer is in talks with federal officials about possibly putting vaccination sites in its...
Published:
Last Updated:
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Novartis AG (NYSE: NVS) shares are at session highs and...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. These are the top 10 early bird analyst upgrades and...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. These are some of the top pre-market analyst upgrades we...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. This weekend will be a potentially important oncology...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. These are some of the many pre-market downgrades and...
Published:
These are some of the top pre-market analyst upgrades and positive calls we have seen on Wall Street this Friday morning: Accuray (ARAY) Raised to Buy at Piper Jaffray. AstraZeneca (AZN) Raised to...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. We have run a full feature story over at...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Last night was a novel release from the American Society...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.